Search research articles
Contact Us
Filters
Showing results (51-60 of 92) with videos related to
Page
of 10
Sort By:
Human Gene Therapy
|
January 20, 1997
Genetic immunotherapy of established tumors with adenovirus-murine granulocyte-macrophage colony-stimulating factor
C T Lee, S Wu, I F Ciernik, et al.
British Journal of Cancer
|
July 17, 1999
Serum anti-p53 antibodies in gastric adenocarcinoma patients are associated with poor prognosis, lymph node metastasis and poorly differentiated nuclear grade
C W Wu, Y Y Lin, G D Chen, et al.
Cancer Research
|
July 1, 1996
Antitumor effects of an adenovirus expressing antisense insulin-like growth factor I receptor on human lung cancer cell lines
C T Lee, S Wu, D Gabrilovich, et al.
Radiology
|
September 1, 1979
A hybrid computerized fluoroscopy technique for noninvasive cardiovascular imaging
D L Ergun, C A Mistretta, R A Kruger, et al.
International Immunology
|
August 1, 1997
Oncogenic mutations in ras create HLA-A2.1 binding peptides but affect their extracellular antigen processing
M C Smith, C D Pendleton, V E Maher, et al.
British Journal of Cancer
|
October 28, 2005
Restoration of TGF-beta signalling reduces tumorigenicity in human lung cancer cells
G Anumanthan, S K Halder, H Osada, et al.
Journal of the National Cancer Institute
|
December 15, 1993
Antibodies against autologous tumor cell proteins in patients with small-cell lung cancer: association with improved survival
S F Winter, Y Sekido, J D Minna, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 1, 1995
Expression of transforming growth factor beta and transforming growth factor beta receptors on AIDS-associated Kaposi's sarcoma
I F Ciernik, B H Krayenbühl Ciernik, C J Cockerell, et al.
Cancer Research
|
July 15, 1993
A mutant p53 tumor suppressor protein is a target for peptide-induced CD8+ cytotoxic T-cells
M Yanuck, D P Carbone, C D Pendleton, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 24, 2001
Dendritic cells transduced with full-length wild-type p53 generate antitumor cytotoxic T lymphocytes from peripheral blood of cancer patients
E Y Nikitina, J I Clark, J Van Beynen, et al.
Page
of 10
Search research articles
Search
Showing results (51-60 of 92) with videos related to
Sort By:
Page
of 10
Human Gene Therapy
|
January 20, 1997
Genetic immunotherapy of established tumors with adenovirus-murine granulocyte-macrophage colony-stimulating factor
C T Lee, S Wu, I F Ciernik, et al.
British Journal of Cancer
|
July 17, 1999
Serum anti-p53 antibodies in gastric adenocarcinoma patients are associated with poor prognosis, lymph node metastasis and poorly differentiated nuclear grade
C W Wu, Y Y Lin, G D Chen, et al.
Cancer Research
|
July 1, 1996
Antitumor effects of an adenovirus expressing antisense insulin-like growth factor I receptor on human lung cancer cell lines
C T Lee, S Wu, D Gabrilovich, et al.
Radiology
|
September 1, 1979
A hybrid computerized fluoroscopy technique for noninvasive cardiovascular imaging
D L Ergun, C A Mistretta, R A Kruger, et al.
International Immunology
|
August 1, 1997
Oncogenic mutations in ras create HLA-A2.1 binding peptides but affect their extracellular antigen processing
M C Smith, C D Pendleton, V E Maher, et al.
British Journal of Cancer
|
October 28, 2005
Restoration of TGF-beta signalling reduces tumorigenicity in human lung cancer cells
G Anumanthan, S K Halder, H Osada, et al.
Journal of the National Cancer Institute
|
December 15, 1993
Antibodies against autologous tumor cell proteins in patients with small-cell lung cancer: association with improved survival
S F Winter, Y Sekido, J D Minna, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 1, 1995
Expression of transforming growth factor beta and transforming growth factor beta receptors on AIDS-associated Kaposi's sarcoma
I F Ciernik, B H Krayenbühl Ciernik, C J Cockerell, et al.
Cancer Research
|
July 15, 1993
A mutant p53 tumor suppressor protein is a target for peptide-induced CD8+ cytotoxic T-cells
M Yanuck, D P Carbone, C D Pendleton, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 24, 2001
Dendritic cells transduced with full-length wild-type p53 generate antitumor cytotoxic T lymphocytes from peripheral blood of cancer patients
E Y Nikitina, J I Clark, J Van Beynen, et al.
Page
of 10